Patent holdings for IPC class A61K 31/00

Total number of patents in this class: 7811

10-year publication summary

502
501
461
429
456
428
457
474
514
297
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Inserm (institut National de La Sante et de La Recherche Medicale)
3364
100
Novartis AG
10730
73
The Regents of the University of California
20059
70
Centre National de La Recherche Scientifique
10516
48
Institut National de La Sante et de La Recherche Medicale (inserm)
2886
48
The Johns Hopkins University
5709
47
The Board of Trustees of the Leland Stanford Junior University
6451
40
Boehringer Ingelheim International GmbH
4642
34
Genentech, Inc.
3994
29
F. Hoffmann-La Roche AG
7941
26
AstraZeneca AB
2908
26
Duke University
3087
26
Gilead Sciences, Inc.
2045
26
Buzzelet Development and Technologies Ltd
95
26
Massachusetts Institute of Technology
10102
25
Cellixbio Private Limited
155
25
LTS Lohmann Therapie-Systeme AG
708
25
Vanda Pharmaceuticals, Inc.
363
25
Centre National de La Recherche Scientifique (cnrs)
3103
25
The Brigham and Women's Hospital, Inc.
2212
23
Other owners 7044